• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用人工智能平台 GPAR 利用大规模基因表达谱对药物作用机制进行建模。

Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform.

机构信息

Beijing Institute of Pharmacology and Toxicology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing, 100850, China.

School of Instrumentation Science and Opto-Electronics Engineering and Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beihang University, Beijing, 100083, China.

出版信息

BMC Bioinformatics. 2021 Jan 7;22(1):17. doi: 10.1186/s12859-020-03915-6.

DOI:10.1186/s12859-020-03915-6
PMID:33413089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7788535/
Abstract

BACKGROUND

Querying drug-induced gene expression profiles with machine learning method is an effective way for revealing drug mechanism of actions (MOAs), which is strongly supported by the growth of large scale and high-throughput gene expression databases. However, due to the lack of code-free and user friendly applications, it is not easy for biologists and pharmacologists to model MOAs with state-of-art deep learning approach.

RESULTS

In this work, a newly developed online collaborative tool, Genetic profile-activity relationship (GPAR) was built to help modeling and predicting MOAs easily via deep learning. The users can use GPAR to customize their training sets to train self-defined MOA prediction models, to evaluate the model performances and to make further predictions automatically. Cross-validation tests show GPAR outperforms Gene set enrichment analysis in predicting MOAs.

CONCLUSION

GPAR can serve as a better approach in MOAs prediction, which may facilitate researchers to generate more reliable MOA hypothesis.

摘要

背景

使用机器学习方法查询药物诱导的基因表达谱是揭示药物作用机制(MOA)的有效方法,这得到了大规模、高通量基因表达数据库的发展的有力支持。然而,由于缺乏无代码和用户友好的应用程序,生物学家和药理学家不容易使用最先进的深度学习方法来构建 MOA 模型。

结果

在这项工作中,开发了一个新的在线协作工具,称为遗传谱-活性关系(GPAR),用于通过深度学习轻松构建和预测 MOA。用户可以使用 GPAR 自定义训练集来训练自定义的 MOA 预测模型,评估模型性能并自动进行进一步预测。交叉验证测试表明,GPAR 在预测 MOA 方面优于基因集富集分析。

结论

GPAR 可以作为一种更好的 MOA 预测方法,这可能有助于研究人员生成更可靠的 MOA 假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/386bca8815d1/12859_2020_3915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/7c96ce4b03b9/12859_2020_3915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/0be171af969a/12859_2020_3915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/6576d5954fca/12859_2020_3915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/386bca8815d1/12859_2020_3915_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/7c96ce4b03b9/12859_2020_3915_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/0be171af969a/12859_2020_3915_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/6576d5954fca/12859_2020_3915_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fffc/7788791/386bca8815d1/12859_2020_3915_Fig4_HTML.jpg

相似文献

1
Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform.利用人工智能平台 GPAR 利用大规模基因表达谱对药物作用机制进行建模。
BMC Bioinformatics. 2021 Jan 7;22(1):17. doi: 10.1186/s12859-020-03915-6.
2
Deep learning applications for the accurate identification of low-transcriptional activity drugs and their mechanism of actions.用于准确识别低转录活性药物及其作用机制的深度学习应用。
Pharmacol Res. 2022 Jun;180:106225. doi: 10.1016/j.phrs.2022.106225. Epub 2022 Apr 20.
3
Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding.使用化合物结构和转录组特征共嵌入预测新型化合物的作用机制。
Bioinformatics. 2021 Jul 12;37(Suppl_1):i376-i382. doi: 10.1093/bioinformatics/btab275.
4
Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury.将药物作用模式整合到定量构效关系中以改进药物性肝损伤的预测
J Chem Inf Model. 2017 Apr 24;57(4):1000-1006. doi: 10.1021/acs.jcim.6b00719. Epub 2017 Apr 10.
5
BubbleGUM: automatic extraction of phenotype molecular signatures and comprehensive visualization of multiple Gene Set Enrichment Analyses.BubbleGUM:表型分子特征的自动提取及多种基因集富集分析的综合可视化
BMC Genomics. 2015 Oct 19;16:814. doi: 10.1186/s12864-015-2012-4.
6
MOASL: Predicting drug mechanism of actions through similarity learning with transcriptomic signature.MOASL:通过转录组特征的相似性学习预测药物作用机制。
Comput Biol Med. 2024 Feb;169:107853. doi: 10.1016/j.compbiomed.2023.107853. Epub 2023 Dec 13.
7
Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes.基于数据驱动的血糖动力学建模与预测:机器学习在 1 型糖尿病中的应用。
Artif Intell Med. 2019 Jul;98:109-134. doi: 10.1016/j.artmed.2019.07.007. Epub 2019 Jul 26.
8
A Qualitative Modeling Approach for Whole Genome Prediction Using High-Throughput Toxicogenomics Data and Pathway-Based Validation.一种使用高通量毒理基因组学数据和基于通路的验证进行全基因组预测的定性建模方法。
Front Pharmacol. 2018 Oct 2;9:1072. doi: 10.3389/fphar.2018.01072. eCollection 2018.
9
Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy.开放 MoA:基于网络拓扑和层次结构揭示作用机制 (MoA)。
Bioinformatics. 2023 Nov 1;39(11). doi: 10.1093/bioinformatics/btad666.
10
Machine Learning Uses Chemo-Transcriptomic Profiles to Stratify Antimalarial Compounds With Similar Mode of Action.机器学习利用化转录组特征对作用模式相似的抗疟化合物进行分层。
Front Cell Infect Microbiol. 2021 Jun 29;11:688256. doi: 10.3389/fcimb.2021.688256. eCollection 2021.

引用本文的文献

1
Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer.结直肠癌精准治疗中药物重新利用的进展与挑战
World J Gastrointest Oncol. 2025 Jul 15;17(7):107681. doi: 10.4251/wjgo.v17.i7.107681.
2
Drug mechanism enrichment analysis improves prioritization of therapeutics for repurposing.药物机制富集分析可提高重新定位治疗药物的优先级。
BMC Bioinformatics. 2023 May 24;24(1):215. doi: 10.1186/s12859-023-05343-8.
3
Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice multiple mechanisms.

本文引用的文献

1
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.通过药理学和 CRISPR 筛选的整合发现药物作用机制。
Mol Syst Biol. 2020 Jul;16(7):e9405. doi: 10.15252/msb.20199405.
2
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.羟氯喹作为 COVID-19 暴露后预防的随机试验。
N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub 2020 Jun 3.
3
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
复方丹参滴丸通过多种机制抑制载脂蛋白E和低密度脂蛋白受体双缺陷小鼠的高胆固醇血症/动脉粥样硬化诱导的心力衰竭。
Acta Pharm Sin B. 2023 Mar;13(3):1036-1052. doi: 10.1016/j.apsb.2022.11.012. Epub 2022 Nov 15.
4
Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer Immunotherapy.人工智能辅助转录组分析推动癌症免疫治疗
J Clin Med. 2023 Feb 6;12(4):1279. doi: 10.3390/jcm12041279.
5
Computational analyses of mechanism of action (MoA): data, methods and integration.作用机制的计算分析:数据、方法与整合
RSC Chem Biol. 2021 Dec 22;3(2):170-200. doi: 10.1039/d1cb00069a. eCollection 2022 Feb 9.
6
Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning.通过利用细胞图像特征和机器学习对作用机制进行建模,加速用于治疗新冠肺炎的药物重新利用。
Cogn Neurodyn. 2023 Jun;17(3):803-811. doi: 10.1007/s11571-021-09727-5. Epub 2021 Nov 5.
瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒(2019 - 新冠病毒)。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
4
Signatures of cell death and proliferation in perturbation transcriptomics data-from confounding factor to effective prediction.扰动转录组学数据中细胞死亡和增殖的特征——从混杂因素到有效预测。
Nucleic Acids Res. 2019 Nov 4;47(19):10010-10026. doi: 10.1093/nar/gkz805.
5
Drug repurposing: progress, challenges and recommendations.药物重定位:进展、挑战和建议。
Nat Rev Drug Discov. 2019 Jan;18(1):41-58. doi: 10.1038/nrd.2018.168. Epub 2018 Oct 12.
6
Deep learning-based transcriptome data classification for drug-target interaction prediction.基于深度学习的转录组数据分类在药物-靶标相互作用预测中的应用。
BMC Genomics. 2018 Sep 24;19(Suppl 7):667. doi: 10.1186/s12864-018-5031-0.
7
Drug Repurposing Using Deep Embeddings of Gene Expression Profiles.基于基因表达谱的深度学习嵌入的药物重定位。
Mol Pharm. 2018 Oct 1;15(10):4314-4325. doi: 10.1021/acs.molpharmaceut.8b00284. Epub 2018 Aug 7.
8
L1000FWD: fireworks visualization of drug-induced transcriptomic signatures.L1000FWD:药物诱导转录组特征的烟花可视化。
Bioinformatics. 2018 Jun 15;34(12):2150-2152. doi: 10.1093/bioinformatics/bty060.
9
gene2drug: a computational tool for pathway-based rational drug repositioning.基因到药物:一种基于通路的药物重定位的计算工具。
Bioinformatics. 2018 May 1;34(9):1498-1505. doi: 10.1093/bioinformatics/btx800.
10
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.下一代连接图谱:L1000平台及首批100万个图谱
Cell. 2017 Nov 30;171(6):1437-1452.e17. doi: 10.1016/j.cell.2017.10.049.